It also plays a massive role in reducing the formation of thick, inflexible scar tissue [3, 6]
This is because obesity is linked to worse outcomes in people with breast cancer, particularly in postmenopausal women
With insulin, there is risk of weight gain, for hypoglycemia, and theres more treatment burden and need for glucose monitoring. GLP-1 drugs have also been shown to have cardiovascular benefits, she adds, though further clinical trials are needed to assess orforgliprons effects on heart health
Patients on tirzepatide lost an average of 20.2% of their body weight over 72 weeks Patients on semaglutide lost an average of 13.7% of their body weight over the same period 47% more tirzepatide patients achieved 25% or greater body weight loss compared to semaglutide Tirzepatide also produced greater reductions in waist circumference across all dose comparisons A 2024 meta-analysis published in JAMA Internal Medicine analyzing real-world data from over 140,000 patients confirmed the same pattern: tirzepatide produced an average of 4.23 kg more weight loss than semaglutide across all doses and durations studied

Boosts energy levels naturally Adults 40+ experiencing fatigue, brain fog, or slower recovery High-performers needing cognitive stamina and decision-making clarity Athletes seeking faster recovery, greater endurance, and less inflammation Post-illness or burnout individuals needing mitochondrial recovery Health optimizers focused on proactive aging and performance NAD powers every cell in your body